Morbidity;Infant
8
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Financially-Incentives to Improve Provider Compliance
Survival and nEonatal outComes of veRy Low Birth wEight Infants in Türkiye: Turkish Neonatal Society SECRETS-TR Study
Morbidity and Mortality Rates Among Children Aged 0-59 Months
Trial to Compare BCG-Bulgaria and BCG-Denmark
Trial to Compare Two Strains of BCG
Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation
Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants
To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants